Lurasidone wins for a composite baker with prediabetes and a pre-dawn shift, while MN663's Unit 2 comparison keeps a full record of what quetiapine would have offered. Searches like "mn 663 unit 2 assignment example", "mn663 unit 2 sample" and "mn663 unit 2 example" land here.
What a finished MN663 Unit 2 medication comparison looks like
A comparison table, then four paragraphs of argument. Rows cover indication, efficacy evidence, weight and glucose effects, sedation, common adverse effects, interactions and administration. Quetiapine's column records its trial base in bipolar depression from the BOLDER studies, alongside marked sedation and a weight and glucose burden that matters for a patient whose A1c is [6.1] percent. Lurasidone's column records its 2013 approval on two six-week trials (Loebel et al., 2014), a smaller metabolic signal, and costs of its own: akathisia and nausea, the requirement to take it with a meal of at least 350 calories, and contraindication with strong CYP3A4 inhibitors or inducers. Both columns carry the same two boxed warnings, each with its subject and year. The argument then weighs those rows against her history and her [3:30 a.m.] alarm.
How a MN663 Unit 2 example is structured
The comparison opens by stating its decision rule before either drug is named: for this patient, metabolic risk and morning function outweigh a modest difference in evidence. The table follows, every cell cited. Argument paragraphs then take the rows in order of weight for her. Metabolic burden comes first, because her A1c and a mother with type 2 diabetes make weight gain the harm with the longest tail. Sedation comes second, since a drug that leaves her groggy before dawn would likely be stopped by her rather than by a prescriber. Efficacy comes third and is handled honestly: quetiapine's evidence is broader, and the paper concedes it. The practical demands of lurasidone, food and interaction limits, close the argument as the price of the choice. Quetiapine's route back to first choice, the circumstances that would restore it, fills the closing paragraph.
A rule written before the drugs
The decision rule appears in the first paragraph, ahead of the table. Because the weighting is fixed in advance, a reader can check whether the conclusion follows from it rather than suspecting the rule was fitted to a preferred answer afterward.
Evidence given its due
Quetiapine's larger trial base in bipolar depression is stated without hedging. Conceding the point makes the eventual choice more persuasive, since the paper shows it knows what the rejected drug does well and chose against it anyway.
Her alarm clock as data
Sedation is judged against her actual morning, a drive to the bakery before four. The same drowsiness that might help another patient sleep becomes, for her, a likely reason to skip doses and a hazard on the road.
What lurasidone asks in return
Akathisia, nausea, a meal with every dose and a short list of forbidden interacting drugs are set out as the costs of the choice. Naming them keeps the comparison from reading as advocacy for the winner.
Conditions that would reverse it
Severe insomnia driving the episode, akathisia that does not settle, or coverage that excludes lurasidone would each tilt the balance back. The paper lists them so the choice reads as conditional on this patient, not as a ranking of drugs.
Where marks go in MN663 Unit 2
Credit on a comparison depends on a choice actually being made, and papers that describe both agents fairly before concluding either would suit have written two drug monographs instead. Weighing rows without saying why one outweighs another for this patient draws the next comment: a table can show that quetiapine sedates, but only the argument can show why sedation matters to someone who drives to work before dawn. Understating the chosen drug's burdens costs marks, so omitting akathisia or the meal requirement reads as advocacy. Both boxed warnings should appear with subject and date, and graders look for them. Citing efficacy from trials in mania when the question concerns depression is a common slip. Minor losses come from an uncited table cell, from amounts stated outside a bracketed composite, and from ignoring coverage entirely.
Get a MN663 Unit 2 example written to your instructions
Which two agents does your MN663 section's Unit 2 prompt name, or is the pair left open? Say which, and include the case and rubric. Expect a decision rule stated before either drug, a cited cell in every row of the table, and the circumstances that would reverse the choice, all in a free first comparison ready within 24-48h.
MN663 Unit 2 questions, answered
Does the comparison have to pick one agent?
Almost always. A comparison that ends in balance has described two drugs rather than compared them. If the case genuinely supports either, choose the one you would start, give the deciding reason, and say what finding would send you to the other. That conditional ending shows judgment, which is what the assignment exists to assess.
How much trial data belongs in the table?
Enough to show where each drug's evidence comes from: the pivotal trials for the indication in question, their length and their comparator. Effect sizes help if the prompt asks for them. Pages of trial detail crowd out the argument, and evidence from a different phase of illness, mania instead of depression, should be flagged or left out.
Should the comparison mention cost and insurance coverage?
Briefly, when the case raises it or when one agent is far more expensive. A plan the patient cannot fill is not a working plan, and graders in management courses tend to credit the recognition. Keep it to a sentence or two unless the prompt makes access a central question, and avoid quoting prices that change by plan and pharmacy.